In the tube assays, the strains containing the chimeric constructs showed a trend towards reduced migration, even compared to the Δ cetAB strain (significantly different at 40 and 48 hrs, as determined by a t-test, Fig.
← all phrases
“showed a trend”
In the literature
Also, the mean failure rate (repeat ablation or hysterectomy for heavy bleeding or persistent pain), although not statistically significant, showed a trend towards a gradual, long-term higher failure rate for the RB-Lupron group, compared to the RB-Novasure group ( Figure 3 ) .
Subgroup analysis according to molecular and histological characteristics indicated that patients with nonsquamous histology showed a trend in favor of tivantinib plus erlotinib in both overall and progression-free survival.
PACAP showed a trend toward dose-dependent increase of neurite outgrowth at 10 −9 M to 10 −8 M, but this was not statistically significant.
In contrast, the anti-GAA IgG1 response was diminished in MyD88KO mice, and showed a trend toward a decrease in TRIFKO mice.
Quantified roughness ( R ) of the surfaces showed a trend of gradual increase, 6.1±1.3 nm, 6.3±1.8 nm, and 6.4±1.2 nm on day 0, 12, and 24, respectively.
Analyses of cytokine responses in this subset showed a trend for decreased IL-7 responses, but preserved IL-2 responses and an absence of reactivity to TSLP.
The cumulative meta-analyses showed a trend of more marked associations between PAI-1 -675 4G/5G polymorphism and increased risk of sepsis and mortality as data accumulated each year.
Intriguingly, the application of U0126 and selumetinib, AZD6244 (an anti-cancer drug in phase I-II clinical trial) to block MEK1 pathway in LMNA R225X/WT and LMNA Framshift/WT iPSC-CMs and shRNA treated control iPSC-CMs showed a trend that attenuated or even completely abolished the apoptotic effects of field electric stimulation on these lamin-deficient cardiomyocytes as seen in the dermal fibroblast (Figure 3 and 6 ) whereas 10 μM of U0126 significantly rescued the rate of apoptosis mediated by electrical stress (11.2 ± 0.8% vs. 4.4 ± 1.4%; n=3, P<0.05 ).
Although all three mutants showed a trend of slightly decreased binding (approximately 80% of WT at 100 nM protein, Fig. 2B ), this difference was not statistically significant.
But this also showed a trend that the external fixation was used as a transitional method and intramedullary nailing as a definitive method in many occasions [ 35 , 36 ].
This result is consistent with previous research in which BL6/DBA mice were fed high zinc diets (300–1000 ppm) for 7–17 months, the brain zinc only showed a trend but no significant elevation [38] .
Patients in the conventional groups showed a trend towards earlier improvements.
None of the neonatal outcomes showed a trend in a worse direction, even among medically indicated PTBs, and instead the Apgar scores and rates of NICU admission improved over time.
A further cluster in right striatum ( p = .06, svc), extending into ventral striatum, also showed a trend towards reduced volume.
Each ACT factor also showed a trend of increasing mean scores ranging from the lowest to the highest level of instrumental research use, adding additional validity evidence.
In their report, NEC with a high eosinophil count showed a trend towards a later time of onset compared with NEC without presentation of systemic eosinophilia [ 23 ], suggesting that a Th2-type adaptive immune response requires immune maturity.
Physiological measures showed a trend, although not significant, to improvement in weight, systolic blood pressure and HDL.
Interestingly, flbA , which represses this signaling pathway showed a trend to down-regulation.
Haplotype analysis showed a trend of decreased LUM susceptibility, in the order of NFD, NYD, YYY, and YYD.
Mice that received OVA plus curdlan also showed a trend of lower IL-1β expression levels than mice that received OVA alone, but the differences only approached statistical significance at 96 hr timepoint (p=0.073).
In the present study, difference in allelic frequency for this site showed a trend to be significant in ALL even after correction for multiple testing, while DS probands, parents of DS probands and BC showed significant differences.
Schildkraut findings showed a trend consistent with our results, but due to relatively smaller groups (118 ovarian cancers vs. 618 controls) the scores were not statistically significant leaving the case open.
The Nottingham Prognostic Index ( Figure 3E and F ) or tumor size ( Figure 3G and H ) showed a trend only towards correlation with CIN4 signature or with DNA index.
Although the data failed to show statistical significance, they showed a trend toward a higher rate of temporary motor deficit in patients in which resection was limited by IOM.